,,iv #aai? ,,congress #b;d ,session ,h4 ,,res4 #ajij ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,febru>y #bf1 #bjbf,mr4 ,veasey 7= himself & ,mr4 ,bilirakis7 submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,express+ support = ! designation ( ,febru>y #bjbf z ,l[ ,vision & ,vision ,impairm5t ,aw>5ess ,mon?4 ,:]eas1 accord+ to ! ,int]national ,ag5cy = ! ,prev5tion ( ,bl9dness 7,,iapb71 #ij p]c5t ( vision or sight loss is prev5table or treatable & yet ! global economy loses an e/imat$ #daa billion to unaddress$ vision problems ea* ye>2 ,:]eas1 accord+ to ! ,,iapb1 ov] #b billion p globally live ) vision impairm5t & yet approximately #a billion p live ) vision loss t c\ld h be5 avoid$ or treat$2 ,:]eas1 accord+ to ! ,c5t]s = ,disease ,control & ,prev5tion 7,,cdc71 approximately #ab million p ov] ! age ( #dj 9 ! ,unit$ ,/ates h vision impairm5t1 includ+ #a million p ) bl9dness & an e/imat$ #d4b million p ov] age #dj h an uncorrectable vision impairm5t2 ,:]eas1 accord+ to ,prev5t ,bl9dness1 vision problems w co/ ! ,u4,s4 ne>ly #bjf billion 9 #bjbf 9 m$ical co/s1 productivity losses1 long-t]m c>e co/s1 & gov]nm5t program co/s1 plac+ significant /ra9 on families1 employ]s1 & public programs2 ,:]eas1 accord+ to ,prev5t ,bl9dness1 by #bjej1 ! impair$ & bl9d populations are project$ to rea* #g4c million & #c4a million1 respectively1 &1 by #bjej1 ! numb] ( ,am]icans ) advanc$/age1 age-relat$ macul> deg5]ation w d\ble to #d4d million1 glaucoma preval5ce w increase to #e4e million1 cat>act w gr[ to #de4f million1 & ! preval5ce ( diabetic ret9opa?y w increase to #ac4b million2 ,:]eas1 accord+ to ! ,,cdc1 diabetes is ! lead+ cause ( bl9dness 9 adults & pati5ts :o h diabetes may (t5 be unaw>e ( ! damage occurr+ to _! eyes1 specifically 9 ! e>ly /ages1 :i* makes e>ly detection1 disease monitor+1 & treatm5t ( diabetes-relat$ eye disease a significant public heal? priority t c r$uce ! risk ( bl9dness by #ij p]c5t2 ,:]eas1 accord+ to ! ,national ,c5t] = ,*ildr5's ,vision & ,eye ,heal? 7,,nccveh71 "o out ( e #abb *ildr5 9 ! ,u4,s41 includ+ "o out ( e #acg *ildr5 ag$ #j-aa & "o out ( e #ajb *ildr5 ag$ #ab-ag h uncorrectable vision loss1 non-,hispanic ,black *ildr5 h ! highe/ rates ( vision loss & bl9dness1 "o out ( e #hi ,black *ildr5 h vision loss1 "o out ( e #a1jjj are p]man5tly bl9d1 & approximately #gfj1jjj *ildr5 enroll$ 9 ,m$icaid & ,/ate ,*ildr5's ,heal? ,insurance ,programs 7,,*ip7 insurance cov]age 7 diagnos$ 9 #bjai ) ei!r amblyopia 7#cfj1jjj *ildr57 or /rabismus 7#dhf1jjj *ildr572 ,:]eas1 accord+ to ! ,,nccveh1 a *ild's vision develops & *anges f bir? ?r\gh *ildhood2 ?us1 necessitat+ t a *ild %\ld be scre5$ regul>ly1 ref]r$ to eye c>e1 & receive any ne$$ treatm5t & foll[-up to c>e to ensure vision problems are caught e>ly & p]man5t vision loss is avoid$2 ,:]eas1 accord+ to ! ,,nccveh1 :ile e>ly detection & int]v5tion = vision disord]s 9 *ildr5 are "p ( national goals & heal? c>e /&>ds1 !re is curr5tly no exi/+ program 9 ! ,unit$ ,/ates t specifically addresses *ildr5's vision & eye heal? despite inve/m5ts 9 o!r aspects ( *ild heal? su* z he>+ & oral heal?2 ,:]eas1 accord+ to ! ,national ,academies ( ,sci5ces1 ,eng9e]+1 & ,m$ic9e 7,,nasem71 ! av]age age = myopia onset is #aa ye>s ) a range ( onset f #g to #af ye>s ) pot5tially lifelong consequ5ces includ+ ret9al deta*m5t1 age-relat$ macul> deg5]ation1 glaucoma1 & o!r pot5tially bl9d+ eye conditions2 ,:]eas1 accord+ to ! ,,nasem1 ! ,u4,s4 ,dep>tm5t ( ,heal? & ,human ,s]vices1 9 collaboration ) dep>tm5ts ( education at ! ,/ate level1 %\ld take measures to ensure t *ildr5 receive a vision scre5+ be=e fir/ grade & a compreh5sive eye exam :5 ne$$1 & t an integrat$1 national data surveillance sy/em is ne$$ = collect+ ,/ate-level data on vision scre5+1 ref]rals to eye c>e provid]s1 sociodemographic 7age1 race_/e?nicity1 sex1 & geographic location71 & outcomes ( ref]rals2 ,:]eas1 accord+ to ! ,,nasem1 vision scre5+s held at community heal? c5t]s & ,f$]ally qualifi$ heal? c5t]s are promis+ ways to connect und]s]v$ populations to vision c>e & t vision scre5+s programs %\ld include a foll[-up compon5t to ensure eye c>e 0 receiv$1 :i* c be successfully execut$ ) ! p>tn]%ip ( eye c>e provid]s1 public heal? units1 public insurance plans 7su* z ,m$icaid & ,,*ip71 e>ly int]v5tion1 & s*ool-bas$ s]vices2 ,:]eas1 accord+ to ! ,national ,alliance = ,eye & ,vision ,rese>* 7,,naevr71 vision rese>*]s are at ! =efront ( gr\ndbreak+ advancem5ts 9 g5e !rapies1 imag+ te*nologies1 artificial intellig5ce1 big data1 & reg5]ative m$ic9e2 ,:]eas1 accord+ to ! ,,naevr1 ! ,u4,s4 is sp5d+ ov] #ehg p] ,am]ican on ! treatm5t ( vision disord]s ?is ye>1 :ile only sp5d+ #b4fd p] ,am]ican on rese>*1 highlight+ an opportunity to /r5g!n prev5tion & innovation ef=ts2 ,:]eas1 accord+ to ! ,national ,eye ,in/itute 7,,nei71 our national inve/m5t 9 vision rese>* has l$ to major advances 9 ! prev5tion & treatm5t ( eye diseases & visual disord]s ?r\gh pione]+ rese>* & te*nologies2 ,:]eas1 accord+ to ! ,,cdc1 vision disability is "o ( ! top #aj disabilities among adults #ah ye>s & old]1 & ! preval5ce ( vision impairm5ts increases ) age2 ,:]eas1 accord+ to ! ,c5t]s = ,m$ic>e & ,m$icaid ,s]vices 7,,cms71 ,m$ic>e does n usually cov] r\t9e vision s]vices su* z eyeglasses1 eye exams1 or contact l5ses nei!r does x cov] l[ vision devices or assi/ive te*nologies = loss ( functional vision1 b glaucoma & diabetes-relat$ eye disease scre5+s & exams1 & c]ta9 diagno/ic te/s & treatm5ts = pati5ts ) age-relat$ macul> deg5]ation1 are cov]$ b5efits2 ,:]eas ^? suff]+ f vision impairm5ts or bl9dness are m likely to develop dem5tia & h tr\ble ) read+1 cook+1 & driv+1 tr\ble 9 dim light1 fad+ or o!r *anges 9 color p]ception1 & difficulty recogniz+ famili> faces1 :i* c increase reliance on c>egiv]s & public s]vices2 ,:]eas1 due to m$ical innovation1 a v>iety ( effective treatm5ts across ! spectrum ( vision impairm5ts & bl9dness are available1 c help pres]ve or improve vision1 & may "o day rev]se ! effects ( ret9al diseases & vision loss2 & ,:]eas _m bl9d+ eye conditions across ! age spectrum t result 9 vision loss or bl9dness are highly prev5table & treatable :5 met ) timely prev5tion1 heal? promotion1 e>ly detection1 int]v5tion1 & access to c>e2 giv5 ! co/-effectiv5ess ( prev5t+ vision loss1 visual impairm5t1 & bl9d+ eye diseases be=e !y happ5 comp>$ to ! high co/ ( treat+ & manag+ vision loss1 visual impairm5ts1 & bl9d+ eye diseases aft] !y h occurr$2 9 consid]ation ( a rapidly ag+ population :o face *anges to ! /ructure & function ( ! eye z a result ( ! ag+ process2 & ) ! promise ( significant advancem5ts 9 treatm5t1 access1 & innovation on ! horizon z a result ( opportunities 9 vision rese>*3 ,n[1 !re=e1 be x ,t ! ,h\se ( ,repres5tatives-- 7#a7 expresses support = rais+ aw>5ess ab\t l[ vision & vision impairm5t2 7#b7 recognizes ! impact ( prev5table vision impairm5t & bl9dness on ,am]icans1 includ+ effects on p]sonal indep5d5ce1 quality ( life1 work=ce p>ticipation1 community heal?1 national productivity1 & heal? c>e co/s2 7#c7 supports access to appropriate & relevant heal? in=mation ab\t risk = eye disease & vision impairm5ts 9 work+ age adults & ag+ ,am]icans--p>ticul>ly z !y relate to *ronic disease--& supports access to appropriate heal? in=mation reg>d+ access to vision c>e & eye heal? s]vices at ! appropriate practice level 7su* z optometri/s1 oph?almologi/s1 or ret9a speciali/s7 & community level 7su* z 9 community heal? c5t]s or f$]ally qualifi$ heal? c5t]s72 7#d7 promotes access to appropriate & relevant in=mation includ+ access to eye c>e1 support s]vices1 & assi/ive devices to p>5ts1 c>egiv]s1 families1 provid]s1 & communities ab\t ! importance ( optimal vision to a *ild's cognitive function+ & motor skill developm5t1 social engagem5t & emotional connection1 le>n+ & academic success1 & long-t]m p]sonal & occupational opportunity2 & 7#e7 affirms ! commitm5t ( ,congress to enc\rage ! ,secret>y ( ,heal? & ,human ,s]vices to-- 7,a7 provide in=mation to pati5ts & heal? c>e provid]s ) respect to age-relat$ macul> deg5]ation1 includ+ geographic atrophy1 neurological causes ( vision loss1 cat>acts1 glaucoma1 diabetic ret9opa?y1 refractive errors1 dry eye1 amblyopia1 color bl9dness1 & o!r eye diseases1 includ+ available scre5+ tools & treatm5t options1 ) a goal ( improv+ quality ( life & heal? outcomes2 7,b7 prioritize & conduct ess5tial surveillance ( vision loss1 eye disease1 & eye conditions t lead to vision loss1 visual impairm5t1 l[ vision1 & bl9dness ?r\gh ! ,vision & ,eye ,heal? ,surveillance ,sy/em 7,,vehss72 7,c7 conduct additional rese>* on ! a=em5tion$ eye diseases & o!rs1 includ+ appropriate support s]vices & treatm5ts2 & 7,d7 conv5e pati5ts1 c>egiv]s1 & eye c>e provid]s & rese>*]s to develop & dissem9ate evid5ce-bas$ in=mation1 tools1 & /udies to help ,am]icans exp]i5c+ ! a=em5tion$ eye diseases & o!rs relat$ to vision impairm5t & bl9dness pres]ve1 protect1 & support _! vision heal?4